Published in Blood Cells Mol Dis on March 04, 2009
Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer (2011) 1.12
Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control. Oncogene (2011) 0.96
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood (2011) 0.92
Isolation and characterization of microRNAs of human mature erythrocytes. Methods Mol Biol (2010) 0.83
Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera. Haematologica (2011) 0.81
Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera. Am J Hematol (2013) 0.79
Implication of microRNAs in the pathogenesis of MDS. Curr Pharm Des (2012) 0.77
JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells. JAKSTAT (2013) 0.76
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell (2007) 9.33
Essential role for Nix in autophagic maturation of erythroid cells. Nature (2008) 6.49
Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood (2001) 6.35
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J (2007) 6.26
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (1995) 5.65
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A (2005) 5.54
Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood (2003) 4.91
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol (2004) 3.76
Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med (1991) 3.48
Myeloproliferative disorders. Blood (2008) 3.37
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol (2007) 2.75
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood (2006) 2.74
Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells. Nat Genet (1992) 2.66
Letter: Bone-marrow responses in polycythemia vera. N Engl J Med (1974) 2.61
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood (2007) 2.40
MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol (2007) 2.40
Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem (2006) 2.39
Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol (2002) 2.03
Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol (2007) 1.98
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood (2007) 1.83
Dynamics of GATA transcription factor expression during erythroid differentiation. Blood (1993) 1.69
Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem (1999) 1.64
The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. Blood (2003) 1.60
Coordination of erythropoiesis by the transcription factor c-Myb. Blood (2006) 1.52
Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Exp Hematol (2004) 1.46
Aberrant expression of microRNA in polycythemia vera. Haematologica (2008) 1.37
Polycythemia vera and other primary polycythemias. Curr Opin Hematol (2005) 1.09
Imatinib effect on growth and signal transduction in polycythemia vera. Exp Hematol (2007) 0.87
The JAK2V617F mutation in polycythemia vera and other myeloproliferative disorders: one mutation for three diseases? Hematology Am Soc Hematol Educ Program (2008) 0.87
Transcription factor GATA-1 and erythroid development. Proc Soc Exp Biol Med (1993) 0.86
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica (2003) 0.85
Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Exp Hematol (2003) 0.84
Functional analysis of the c-myb proto-oncogene. Curr Top Microbiol Immunol (1996) 0.79
In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia. Eur J Clin Invest (1998) 0.77
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood (2006) 8.56
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55
Essential role for Nix in autophagic maturation of erythroid cells. Nature (2008) 6.49
Genetic evidence for high-altitude adaptation in Tibet. Science (2010) 5.37
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet (2002) 4.06
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood (2005) 3.24
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol (2002) 2.77
Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol (2007) 2.75
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med (2012) 2.74
Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem (2006) 2.39
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood (2004) 2.27
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood (2004) 2.12
X-linked clonality testing: interpretation and limitations. Blood (2007) 2.04
Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica (2006) 2.04
Congenital polycythemias/erythrocytoses. Haematologica (2005) 1.99
Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol (2007) 1.98
Hematopoiesis is not clonal in healthy elderly women. Blood (2008) 1.95
Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood (2002) 1.65
Genetic association analysis of chronic mountain sickness in an Andean high-altitude population. Haematologica (2005) 1.59
Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study. Leuk Res (2010) 1.54
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood (2003) 1.52
Copper deficiency masquerading as myelodysplastic syndrome. Blood (2002) 1.51
Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Leuk Lymphoma (2012) 1.46
Aberrant expression of microRNA in polycythemia vera. Haematologica (2008) 1.37
The evolution of cellular deficiency in GATA2 mutation. Blood (2013) 1.36
Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood (2005) 1.35
Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica (2008) 1.33
Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem (2007) 1.32
New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol (2013) 1.32
Vascular complications in Chuvash polycythemia. Semin Thromb Hemost (2006) 1.29
Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis (2002) 1.28
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele. Exp Hematol (2007) 1.26
Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res (2006) 1.24
Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development (2004) 1.21
Genetic determinants of Tibetan high-altitude adaptation. Hum Genet (2011) 1.21
Lessons from familial myeloproliferative disorders. Semin Hematol (2005) 1.20
Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica (2010) 1.16
Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. Development (2004) 1.14
Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood (2007) 1.13
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med (Berl) (2012) 1.13
Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. Am J Hum Genet (2003) 1.10
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood (2013) 1.07
The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. Blood (2003) 1.07
Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One (2009) 1.07
Divalent metal transporter 1. Hematology (2005) 1.07
Hypoxia. 5. Hypoxia and hematopoiesis. Am J Physiol Cell Physiol (2011) 1.07
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia. Blood (2011) 1.06
miR-451 enhances erythroid differentiation in K562 cells. Leuk Lymphoma (2010) 1.06
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts. J Hematol Oncol (2013) 1.05
Sickle cell disease resulting from uniparental disomy in a child who inherited sickle cell trait. Blood (2010) 1.04
Zap1 activation domain 1 and its role in controlling gene expression in response to cellular zinc status. Mol Microbiol (2005) 1.04
Treatment target in polycythemia vera. N Engl J Med (2013) 1.02
The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica (2013) 0.97
New onset of myelofibrosis in association with pulmonary arterial hypertension. Ann Intern Med (2005) 0.97
Familial polycythemia caused by a novel mutation in the beta globin gene: essential role of P50 in evaluation of familial polycythemia. Int J Med Sci (2007) 0.96
A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia. Haematologica (2006) 0.95
Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). Haematologica (2011) 0.94
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood (2011) 0.94
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age. Br J Haematol (2011) 0.93
Metabolic insight into mechanisms of high-altitude adaptation in Tibetans. Mol Genet Metab (2012) 0.93
Methylation of AR locus does not always reflect X chromosome inactivation state. Blood (2012) 0.93
Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation (2014) 0.92
Convergent mechanisms of somatic mutations in polycythemia vera. Discov Med (2011) 0.91
Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells. Blood (2004) 0.91
Zinc metalloregulation of the zinc finger pair domain. J Biol Chem (2006) 0.91
Regulation of ferrochelatase gene expression by hypoxia. Life Sci (2004) 0.90
Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism. J Mol Med (Berl) (2012) 0.90
Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment. Biol Blood Marrow Transplant (2007) 0.90
Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer. Blood (2013) 0.89
The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia. Haematologica (2011) 0.89
Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients. Haematologica (2005) 0.88
Imatinib effect on growth and signal transduction in polycythemia vera. Exp Hematol (2007) 0.87
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis. Blood (2004) 0.86
JAK2 kinase inhibitors and myeloproliferative disorders. Curr Opin Hematol (2010) 0.86
Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia. Br J Haematol (2010) 0.86
The HIF2A gene in familial erythrocytosis. N Engl J Med (2008) 0.86
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients. Haematologica (2005) 0.85
A quantitative allele-specific PCR test for the BRAF V600E mutation using a single heterozygous control plasmid for quantitation: a model for qPCR testing without standard curves. J Mol Diagn (2013) 0.85
DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. Blood (2006) 0.85
HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis. J Mol Med (Berl) (2015) 0.84
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Gaza Strip Palestinians. Blood Cells Mol Dis (2012) 0.84
Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha. J Mol Med (Berl) (2010) 0.84